Please login to the form below

Not currently logged in
Email:
Password:

The Foundry Healthcare appoints new head

Gerry Montgomery joins as head of healthcare

Gerry MontgomeryCreative communications agency The Foundry Healthcare has appointed Gerry Montgomery as its head of healthcare.

Montgomery has over 20 years’ agency experience managing high profile projects and events for pharmaceutical and medical device brands.

He said: “From my very first meeting with Mark and the team, I knew this would be the perfect move; their creativity and passion were very clear to me.

“I am particularly impressed with the agency’s approach to helping clients overcome sector-specific challenges using a combination of research-based insights, strategy development and creative solutions to inform and influence clinicians, budget holders and patients.

“I’m excited to be joining The Foundry Healthcare at such a pivotal time and to contributing to its continued growth.”

Working alongside The Foundry’s managing director, Mark Bottomley, Montgomery will be responsible for leading the healthcare team, developing the overall business strategy and playing a role in the continued growth of the agency.

Bottomley said: “Gerry’s strong leadership and industry experience will help us build on our accomplishments and drive us forward to the next level.”

11th August 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....

Infographics